ClinicalTrials.gg
CompletedNCT07905040Updated Oct 29, 2026

GENERATİVE AI-SUPPORTED NURSİNG PROCESS EDUCATİON AND NURSİNG STUDENTS' LEARNİNG OUTCOMES

An interventional study of Generative AI-Supported Nursing Process Education and Case Study-Based Nursing Process Education in Nursing Education, Nursing Process and Learning Outcome, sponsored by Istanbul Medipol University Hospital. Completed at 1 site in Turkey (Türkiye). Per ClinicalTrials.gov, last updated 2026-10-29.

Primary conditionAnxiety Disorders(the registry's first term)UnverifiedIs this wrong?The registry often attaches Anxiety Disorders to studies about something else, and this study's title and listed conditions do not name it. No better condition is named, so the registry's term is kept.

Sponsored by Istanbul Medipol University Hospital · Not applicable, Interventional, and Other

From the registry’s dates

  • Registered 7 months after the study started (first participant enrolled Mar 2026, registered Oct 2026).
Updated Oct 29, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
173
Allocation
Randomized
Sex
All
01

Study summary

This randomized controlled trial evaluated the effect of generative artificial intelligence (AI)-supported education in teaching the nursing process on nursing students' learning outcomes. The study was conducted with undergraduate nursing students enrolled in the Nursing Process course for the first time at a foundation university in Istanbul, Türkiye. After a 7-week instructor-centered theoretical course, students were randomly assigned to an intervention or control group using computer-based simple randomization. Over three consecutive weeks, the intervention group worked on three patient case scenarios using a generative AI platform (Gemini), guided by pre-defined themes and prompts covering data collection, nursing diagnosis, planning, and implementation. The accuracy, consistency, and alignment of AI-generated responses with the nursing process steps were then discussed in class. During the same period, the control group completed three different case studies using the instructor's standard care plan template. Nursing process knowledge, self-efficacy in clinical performance, and clinical decision-making confidence and anxiety were measured before and after the intervention, and attitudes toward artificial intelligence and the course were measured after the intervention.

A total of 173 eligible students were randomized (intervention n = 85; control n = 88), and the study was completed with 140 students (intervention n = 68; control n = 72). Students who were repeating the course or were horizontal or vertical transfer students were excluded. The primary outcome was nursing process knowledge, measured with a researcher-developed Nursing Process Knowledge Test. Secondary outcomes were measured with the Self-Efficacy in Clinical Performance Scale, the Nursing Anxiety and Self-Confidence with Clinical Decision Making Scale, and the Attitude Toward Artificial Intelligence and Its Course Scale. Data were collected through electronic forms and analyzed using IBM SPSS 22.0.

02

Conditions studied

  • Nursing Education
  • Nursing Process
  • Learning Outcome
  • Generative Artificial Intelligence

Browse trials for

Keywords

  • Generative Artificial Intelligence
  • Nursing Process
  • Nursing Students
  • Nursing Education
  • Learning Outcomes
  • Self-Efficacy
  • Clinical Decision-Making
  • Anxiety
  • Randomized Controlled Trial
03

In context

Anxiety Disorders Unverified

7,201 studies on the registry are indexed under Anxiety Disorders; 1,682 are open to participants now.

This study's enrollment of 173 is above the median of 80 across 6,057 interventional studies indexed under Anxiety Disorders.

Browse Anxiety Disorders studies →

Lead sponsor

Istanbul Medipol University Hospital is the lead sponsor of 366 studies on the registry; 46 are open to participants now.

Compared within Anxiety Disorders, the registry's first condition term, which may not be this study's main condition. Counted across the registry records on this site, refreshed daily. How we classify →

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Being enrolled in the Nursing Process course for the first time
  • Having no physical, cognitive, or communicative impairment that would prevent participation in the artificial intelligence-supported education program
  • Being informed about the study and volunteering to participate

Exclusion criteria

Exclusion Criteria:

  • Repeating the Nursing Process course
  • Being a horizontal or vertical transfer student
  • Not having completed the pretest measurements
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
173 participants (actual)

Study arms

  • Experimental
    Generative AI-Supported Nursing Process Education

    Over three consecutive weeks, students worked on a different patient case scenario each week (week 1: diabetic foot; week 2: hyponatremia; week 3: primiparous cesarean birth) using a generative AI platform. Each week focused on a different step of the nursing process (week 1: data collection and assessment; week 2: nursing diagnosis; week 3: planning and implementation) and was guided by pre-defined themes and prompts. AI-generated responses were discussed in class for accuracy, consistency, and alignment with the nursing process steps.

    Behavioral: Generative AI-Supported Nursing Process Education

  • Active comparator
    Case Study-Based Nursing Process Education

    Over three consecutive weeks, students completed three different patient case studies, one each week, focusing on the nursing process steps (week 1: data collection and assessment; week 2: nursing diagnosis; week 3: planning and implementation), using concept mapping, without the use of generative AI.

    Behavioral: Case Study-Based Nursing Process Education

Interventions

  • BehavioralGenerative AI-Supported Nursing Process Education

    Students used a generative AI platform for three consecutive weeks, working on one patient case per week (diabetic foot, hyponatremia, primiparous cesarean birth). Each case was analyzed through pre-defined themes and guiding prompts that covered the nursing process steps: data classification and interpretation, nursing diagnosis formulation and justification, prioritization, planning, and implementation. Students were expected to use only the prepared prompts and to report their analyses. AI-generated responses were then discussed in class for accuracy, consistency, and alignment with the nursing process steps. The intervention followed a 7-week instructor-centered theoretical course.

  • BehavioralCase Study-Based Nursing Process Education

    Students completed three different patient case studies over three consecutive weeks, one per week, as part of routine instruction. Each case study was completed using concept mapping, without the use of generative AI. The intervention followed the same 7-week instructor-centered theoretical course as the intervention group.

06

What researchers measure

Primary outcomes

  1. Change in nursing process knowledge score

    Nursing process knowledge was measured with the researcher-developed Nursing Process Knowledge Test, a multiple-choice test covering data collection, nursing diagnosis, planning, implementation, and evaluation. Each question has four options and one correct answer. Correct answers are scored 1 and incorrect or blank answers 0. Total scores range from 0 to 10; higher scores indicate a higher level of nursing process knowledge. The same test was administered at three time points.

    Time frame: Baseline (before the theoretical course), after the theoretical course (before randomization), and immediately after completion of the 3-week intervention

Secondary outcomes

  1. Change in self-efficacy in clinical performance score

    Self-efficacy in clinical performance was measured with the Self-Efficacy in Clinical Performance Scale (Cheraghi et al., 2009; Turkish version by Pozam and Zaybak, 2016). The scale has 37 items in four subscales: data collection, diagnosis and planning, implementation, and evaluation. Each item is rated from 0% (not sure) to 100% (completely sure). Higher scores indicate higher self-efficacy in clinical performance.

    Time frame: Baseline (before the theoretical course) and immediately after completion of the 3-week intervention

  2. Change in clinical decision-making confidence score

    Confidence in clinical decision-making was measured with the confidence section of the Nursing Anxiety and Self-Confidence with Clinical Decision Making Scale (White, 2011; Turkish version by Bektas et al., 2017). The section has 27 items rated on a 6-point Likert scale; total scores range from 27 to 162. Higher scores indicate higher confidence in clinical decision-making.

    Time frame: Baseline (before the theoretical course) and immediately after completion of the 3-week intervention

  3. Change in clinical decision-making anxiety score

    Anxiety in clinical decision-making was measured with the anxiety section of the Nursing Anxiety and Self-Confidence with Clinical Decision Making Scale (White, 2011; Turkish version by Bektas et al., 2017). The section has 27 items rated on a 6-point Likert scale; total scores range from 27 to 162. Lower scores indicate lower anxiety in clinical decision-making.

    Time frame: Baseline (before the theoretical course) and immediately after completion of the 3-week intervention

  4. Attitude toward artificial intelligence and the course score

    Attitudes toward artificial intelligence and the course were measured with the Attitude Toward Artificial Intelligence and Its Course Scale (Suh and Ahn, 2022; Turkish version by Benzer et al., 2025). The scale has 22 items in three subscales (cognitive, affective, behavioral), rated from 1 (strongly disagree) to 5 (strongly agree). Higher scores indicate more positive attitudes.

    Time frame: Immediately after completion of the 3-week intervention

07

Study locations

1 site
  • Istanbul Medipol University
    Beykoz, Istanbul 34810, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Mar 2026 to primary completion in Jun 2026, 2 months.

Of 3,836 non-industry interventional studies with no phase under Anxiety Disorders, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 28. This study's 2 months is below that.

Counting every sponsor, half of 3,938 studies reached it within 12 months; a quarter within 5 and three quarters within 28.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 27, 2026
First posted
Oct 29, 2026
StartActual
Mar 27, 2026
Primary completionActual
Jun 25, 2026
CompletionActual
Jun 25, 2026
Last update
Oct 29, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Oct 29, 2026
Show all 1 update
  1. Oct 29, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07905040
Responsible party
Rabia Yaman Eren (Assistant Professor, Istanbul Medipol University Hospital) — Principal investigator
First posted
Oct 29, 2026
Start date
Mar 27, 2026
Primary completion
Jun 25, 2026
Completion
Jun 25, 2026
Last update
Oct 29, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion